SynergEyes Appoints Bob Ferrigno Chief Executive Officer as Company Ramps up its Specialty Business

Carlsbad, CA (July 3, 2018) – The SynergEyes, Inc. Board of Directors appointed Bob Ferrigno as Chief Executive Officer, effective June 27, 2018. Ferrigno joined SynergEyes in 2015, bringing a wealth of experience and expertise in the Health Care, Optometry, Medical Device, and Diagnostic Industries. At SynergEyes he has led the sales and marketing efforts in expanding the company from a hybrid contact lens company to a specialty contact lens company. His team was responsible for launching the SynergEyes VS scleral contact lens, and is currently marketing and selling the new SimplifEyes soft daily contact lens brand. At SynergEyes Ferrigno has also led the implementation of programs formulated to strengthen services and support for eye care professionals and their patients.

Prior to joining SynergEyes, Ferrigno served as the President of North America for CooperVision (COO). While at CooperVision, he led the integration of the $1.2B Sauflon contact lens company acquisition, focusing on sales infrastructure, logistics, operations and an aggressive launch strategy to rapidly grow contact lens sales in the one-day contact lens segment.

Prior to COO, Ferrigno held executive and general management positions with Becton Dickinson (BD), a global medical technology company, for 32 years, managing key areas including sales, marketing, international operations and global research and development. During his career with BD Ferrigno held numerous positions with increasing levels of responsibility including Vice President of Global Expansion, Vice President of Global Strategic Marketing and Vice President of Research and Development. In addition, Ferrigno served 12 years in general management positions, including having responsibilities for the European pre-analytical systems business unit in the United Kingdom, and as General Manager for international business for the company’s women’s health and cancer business.

Ferrigno is succeeding James Kirchner, OD, who will assume the role of President Emeritus. Dr. Kirchner will continue to develop and foster relationships within the U.S. eye care community, be involved in new product development, and advocate for SynergEyes contact lenses in the areas of myopia management, presbyopia and other eye conditions.

About SynergEyes, Inc.
SynergEyes is an advanced-technology, high-performance contact lens company focused exclusively on the leading independent eye care professionals. SynergEyes manufactures and markets hybrid contact lenses for astigmatism with Duette® and Duette® Progressive and the UltraHealth® lens for irregular corneas, all available with Tangible Hydra-PEG polymers. The SynergEyes portfolio also includes the SynergEyes VS scleral lens and SynergEyes corneal RGP designs. More information is available at

For more information contact:
Heidi Noorany, Senior Director of Marketing, SynergEyes

Recent Posts

CooperVision Adds SynergEyes to Expand Specialty Contact Lens Adoption

CooperVision Adds SynergEyes to Expand Specialty Contact Lens Adoption

SynergEyes launches SynergEyes VS™ Multifocal Scleral Lens

SynergEyes launches SynergEyes VS™ Multifocal Scleral Lens

Other Line Enhancements include Aberration Control and Limbal Clearance Factor Options

Carlsbad, CA (January 18, 2022) – SynergEyes,...